Effectiveness of shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: a preliminary report

Psychiatry Clin Neurosci. 1996 Dec;50(6):341-2. doi: 10.1111/j.1440-1819.1996.tb00578.x.

Abstract

We investigated the efficacy of Shakuyaku-kanzo-to (TJ-68) in neuroleptic-induced hyperprolactinemia in 11 treated schizophrenic patients. The mean plasma prolactin level decreased significantly from 28.9 +/- 14.5 ng/mL at baseline to 22.0 +/- 15.2 ng/mL at 4 weeks. Potassium levels did not change significantly. Neither the exacerbation of psychosis nor other adverse effects occurred.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Drugs, Chinese Herbal / therapeutic use*
  • Glycyrrhiza
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / therapy
  • Male
  • Middle Aged
  • Paeonia
  • Prolactin / blood
  • Schizophrenia / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antipsychotic Agents
  • Drug Combinations
  • Drugs, Chinese Herbal
  • shakuyaku-kanzoh-toh
  • Prolactin